Mild or lower pressure hyperbaric oxygen therapy (aka m-HBOT) was able to demonstrate a marked reduction in Parkinson’s Disease (PD) symptoms in just 11 weeks! PD is a common progressive neurodegenerative disease, of which the main neuropathological hallmark is dopaminergic neuronal loss (degeneration or loss of dopamine-producing neuronal cells). When dopamine-producing neurons die, motor functioning is affected and symptoms such as tremor, slowness, stiffness, and balance problems occur. In this 11 week study, m-HBOT at 1.3 ATA (3 hours per day, 3 times per week) was able to protect the dopaminergic neurons from further loss and degeneration. More importantly, researchers observed positive effects in motor function <view study> Read Less

We all know how difficult it can be to multitask, whether it’s at work or in the home environment. For some of us, it comes easily and is almost like a natural instinct, while for the majority of us, this simple exercise is one that takes a lot of effort and becomes a continual and constant struggle to perform. The good news is that a new study has just shown us that we can improve both single task and multitask performance through the use of hyperbaric oxygen therapy (HBOT). “The study's findings indicate that even for healthy individuals, oxygen at normal conditions is a limiting factor for brain activity. The ability to perform cognitive and/or motor tasks as a single or a combined task (multitask) was evaluated at a normal air/oxygen environment and at HBO, a hyperbaric oxygen enriched environment. Increasing oxygenation using a HBO environment significantly enhanced both cognitive and motor performance. Significant improvements were found for both single tasks as well as simultaneous multiple tasks” <view study> Read Less

The Neurobiology of Aging has just published a study supporting the use of hyperbaric oxygen therapy (HBOT) for Alzheimer’s disease (AD). In this study, they demonstrated the positive impact of HBOT on many of the commonly-found underlying pathologies that are observed in the AD brain. A key focus of this study was on HBOT’s ability to basically halt and reverse the neuro-inflammatory disease progression involved in AD <view study> Read Less

A relatively new category of chronic infections caused by bacteria growing in slime-enclosed aggregates known as biofilms is now becoming one of the major focus topics in clinical research, as it affects millions of people in the developed world each year and in turn is responsibilities for many deaths as a result. Biofilm infections can be extremely difficult to treat, particularly in cases such as pneumonia in cystic fibrosis patients, chronic wounds, chronic otitis media and implant- and catheter-associated infections. “The findings in this study highlight that oxygenation by HBOT improves the bactericidal activity of ciprofloxacin on P. aeruginosa biofilm and suggest that bacterial biofilms is sensitized to antibiotics by supplying hyperbaric O2.” <view study> Read Less

Triple-negative breast cancer (TNBC) is considered to be one of the more aggressive types of breast cancer, and is typically treated with chemotherapy. Cancers like these that are able to rapidly grow and spread are a major concern and need to be treated with an equally aggressive solution. This is why we are seeing more research and clinical trials utilizing combination therapies in order to help intensify the cytotoxic effects of chemotherapy in an aggressive measure to counteract these highly metastatic cancers. This report followed a 29 year old female that was put on an aggressive combination of chemotherapy, hyperthermia therapy, hyperbaric oxygen therapy, and a ketogenic diet. The results were remarkable and “presents evidence of a complete clinical, radiological, and pathological response following a six-month treatment period using this novel combination therapy in a patient with stage IV TNBC” <view study> Read Less